Jenburkt Pharma Stock Price Analysis and Quick Research Report. Is Jenburkt Pharma an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Jenburkt Pharma. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Jenburkt Pharma has a PE ratio of 12.3039798888239 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Jenburkt Pharma has ROA of 16.607% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Jenburkt Pharma has a Current ratio of 4.1081.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Jenburkt Pharma has a ROE of 18.8364%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Jenburkt Pharma has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Jenburkt Pharma has reported revenue growth of 11.2393% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Jenburkt Pharma for the current financial year is 25.9216217081129%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Jenburkt Pharma is Rs 20.7 and the yield is 2.2369%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Jenburkt Pharma is Rs 74.3865. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Jenburkt Pharma in Ticker for free. Also, one can get the intrinsic value of Jenburkt Pharma by using Valuation Calculators, which are available with a Finology ONE subscription. 

Jenburkt Pharma FAQs

Q1. What is Jenburkt Pharma share price today?
Ans: The current share price of Jenburkt Pharma is Rs 915.25.

Q2. What is the market capitalisation of Jenburkt Pharma?
Ans: Jenburkt Pharma has a market capitalisation of Rs 403.9272825 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Jenburkt Pharma?
Ans: The PE ratio of Jenburkt Pharma is 12.3039798888239 and the P/B ratio of Jenburkt Pharma is 1.99052291433868, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Jenburkt Pharma share?
Ans: The 52-week high share price of Jenburkt Pharma is Rs 1073.9, and the 52-week low share price of Jenburkt Pharma is Rs 910.

Q5. Does Jenburkt Pharma pay dividends?
Ans: Currently, Jenburkt Pharma pays dividends. Dividend yield of Jenburkt Pharma is around 2.2369%.

Q6. What are the face value and book value of Jenburkt Pharma shares?
Ans: The face value of Jenburkt Pharma shares is Rs 10, while the book value per share of Jenburkt Pharma is around Rs 459.8038. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Jenburkt Pharma?
Ans: Jenburkt Pharma has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Jenburkt Pharma?
Ans: The ROE of Jenburkt Pharma is 18.8364% and ROCE of Jenburkt Pharma is 25.3406%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Jenburkt Pharma a good buy for the long term?
Ans: The Jenburkt Pharma long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Jenburkt Pharma undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Jenburkt Pharma appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Jenburkt Pharma’s financials?
Ans: You can review Jenburkt Pharma’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.